Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adults. (24th February 2016)

• Record Type: Journal Article
• Authors: Yilmaz, R.; Behnke, S.; Liepelt‐Scarfone, I.; Roeben, B.; Pausch, C.; Runkel, A.; Heinzel, S.; Niebler, R.; Suenkel, U.; Eschweiler, G. W.; Maetzler, W.; Berg, D.
• Is Part Of: European journal of neurology. Volume 23:Number 5(2016:May)
• Page Start: 973
• Page End: 978
• Publication Date: 2016-02-24
• Subjects: Parkinson's disease cognition -- substantia nigra hyperechogenicity -- transcranial sonography -- verbal memory; Neurology -- Periodicals; Nervous system -- Diseases -- Periodicals; 616.8
• DOI: 10.1111/ene.12974
• Languages: English
• ISSNs: 1351-5101

Abstract

Abstract : Background and purpose: Deficits in cognition have been reported in Parkinson's disease (PD) already in the early and even in the pre‐motor stages. Whilst substantia nigra hyperechogenicity measured by transcranial B‐mode sonography (TCS) represents a strong PD marker and is associated with an increased risk for PD in still healthy individuals, its association with cognitive performance in prodromal PD stages is not well established. Methods: Two different cohorts of healthy elderly individuals were assessed by TCS and two different neuropsychological test batteries covering executive functions, verbal memory, language, visuo‐constructional function and attention. Cognitive performance was compared between individuals with hyperechogenicity (SN+) and without hyperechogenicity (SN−). Results: In both cohorts, SN+ individuals performed significantly worse than the SN− group in tests assessing verbal memory (word list delayed recall P = 0.05, logical memory II P < 0.017). Significant differences in Mini‐Mental State Examination score (cohort 1, P = 0.02) and executive function tests (cohort 2, Stroop Color−Word Reading, P = 0.004) could only be shown in one of the two cohorts. No between‐group effects were found in other cognitive tests and domains. Conclusions: These results indicate that individuals with the PD risk marker SN+ perform worse in verbal memory compared to SN− independent of the assessment battery. Memory performance should be assessed in detail in individuals at risk for PD.